These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26197769)

  • 1. Pretreatment risk factors for parametrial involvement in FIGO stage IB1 cervical cancer.
    Yamazaki H; Todo Y; Okamoto K; Yamashiro K; Kato H
    J Gynecol Oncol; 2015 Oct; 26(4):255-61. PubMed ID: 26197769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parametrial involvement in FIGO stage IB1 cervical carcinoma diagnostic impact of tumor diameter in preoperative magnetic resonance imaging.
    Kamimori T; Sakamoto K; Fujiwara K; Umayahara K; Sugiyama Y; Utsugi K; Takeshima N; Tanaka H; Gomi N; Takizawa K
    Int J Gynecol Cancer; 2011 Feb; 21(2):349-54. PubMed ID: 21721193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model for prediction of parametrial involvement and feasibility of less radical resection of parametrium in patients with FIGO stage IB1 cervical cancer.
    Chang SJ; Bristow RE; Ryu HS
    Gynecol Oncol; 2012 Jul; 126(1):82-6. PubMed ID: 22516661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical tumor diameter and prognosis of patients with FIGO stage IB1 cervical cancer (JCOG0806-A).
    Kato T; Takashima A; Kasamatsu T; Nakamura K; Mizusawa J; Nakanishi T; Takeshima N; Kamiura S; Onda T; Sumi T; Takano M; Nakai H; Saito T; Fujiwara K; Yokoyama M; Itamochi H; Takehara K; Yokota H; Mizunoe T; Takeda S; Sonoda K; Shiozawa T; Kawabata T; Honma S; Fukuda H; Yaegashi N; Yoshikawa H; Konishi I; Kamura T;
    Gynecol Oncol; 2015 Apr; 137(1):34-9. PubMed ID: 25662625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix.
    Takeda M; Sakuragi N; Okamoto K; Todo Y; Minobe S; Nomura E; Negishi H; Oikawa M; Yamamoto R; Fujimoto S
    Acta Obstet Gynecol Scand; 2002 May; 81(5):451-7. PubMed ID: 12027820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative outcomes of MR-invisible stage IB1 cervical cancer.
    Park JY; Lee JW; Park BK; Lee YY; Choi CH; Kim TJ; Bae DS; Kim BG; Park JJ; Park SY; Kim CK
    Am J Obstet Gynecol; 2014 Aug; 211(2):168.e1-7. PubMed ID: 24607752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk factors and prognosis of node-positive cervical carcinoma].
    Feng SY; Zhang YN; Liu JG
    Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study.
    Li X; Zhou J; Huang K; Tang F; Zhou H; Wang S; Jia Y; Sun H; Ma D; Li S
    PLoS One; 2015; 10(4):e0122361. PubMed ID: 25860888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
    Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
    Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-operative surgical algorithm: sentinel lymph node biopsy as predictor of parametrial involvement in early-stage cervical cancer.
    Balaya V; Bresset A; Guani B; Benoit L; Magaud L; Bonsang-Kitzis H; Ngo C; Mathevet P; Lécuru F;
    Int J Gynecol Cancer; 2020 Sep; 30(9):1317-1325. PubMed ID: 32753560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative magnetic resonance imaging criteria for predicting lymph node metastasis in patients with stage IB1-IIA2 cervical cancer.
    He F; Zu S; Chen X; Liu J; Yi Y; Yang H; Wang F; Yuan S
    Cancer Med; 2021 Aug; 10(16):5429-5436. PubMed ID: 34278729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic Resonance Imaging as a Valuable Tool for Predicting Parametrial Invasion in Stage IB1 to IIA2 Cervical Cancer.
    Kim M; Suh DH; Kim K; Lee HJ; Kim YB; No JH
    Int J Gynecol Cancer; 2017 Feb; 27(2):332-338. PubMed ID: 28114236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Predictive Model for Parametrial Invasion in Patients With FIGO Stage IB Cervical Cancer: Individualized Approach for Primary Treatment.
    Kong TW; Piao X; Chang SJ; Paek J; Lee Y; Lee EJ; Ryu HS
    Int J Gynecol Cancer; 2016 Jan; 26(1):184-91. PubMed ID: 26512782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative MRI criteria for trials on less radical surgery in Stage IB1 cervical cancer.
    Lee JY; Youm J; Kim TH; Cho JY; Kim MA; Suh DH; Lim MC; Kim JW; Park NH; Song YS
    Gynecol Oncol; 2014 Jul; 134(1):47-51. PubMed ID: 24768849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with parametrial involvement in stage IB1 cervical cancer and identification of patients suitable for less radical surgery.
    Kodama J; Kusumoto T; Nakamura K; Seki N; Hongo A; Hiramatsu Y
    Gynecol Oncol; 2011 Sep; 122(3):491-4. PubMed ID: 21703671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Parametrial involvement in cervical cancer IB1 patients treated with radical hysterectomy in Peru].
    Urrutia C; Santos C; Zevallos A; López A; Montoya A; Sánchez M; Valdivia H; Velarde C; Mantilla R; Esperanza M; Castañeda C; Zaharia M; Álvarez M
    Rev Peru Med Exp Salud Publica; 2014; 31(3):431-6. PubMed ID: 25418639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Validity of Using Human Squamous Cell Carcinoma Associated Antigen and Cytokeratin 19 Fragment Antigen 21-1 to Predict Postoperative Adjuvant Radiotherapy for Nonbulky Early-Stage Squamous Cell Carcinoma of the Cervix.
    Liu CZ; Zeng HX; Zhao JJ; Rong Y; Mo ZL; Li LA; Zhang JQ
    Int J Gynecol Cancer; 2017 Jun; 27(5):994-1000. PubMed ID: 28498239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
    Gaarenstroom KN; Kenter GG; Bonfrer JM; Korse CM; Van de Vijver MJ; Fleuren GJ; Trimbos JB
    Gynecol Oncol; 2000 Apr; 77(1):164-70. PubMed ID: 10739706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCC-Ag, lymph node metastases and sentinel node procedure in early stage squamous cell cervical cancer.
    van de Lande J; Davelaar EM; von Mensdorff-Pouilly S; Water TJ; Berkhof J; van Baal WM; Kenemans P; Verheijen RH
    Gynecol Oncol; 2009 Jan; 112(1):119-25. PubMed ID: 19007978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperatively Assessable Clinical and Pathological Risk Factors for Parametrial Involvement in Surgically Treated FIGO Stage IB-IIA Cervical Cancer.
    Canaz E; Ozyurek ES; Erdem B; Aldikactioglu Talmac M; Yildiz Ozaydin I; Akbayir O; Numanoglu C; Ulker V
    Int J Gynecol Cancer; 2017 Oct; 27(8):1722-1728. PubMed ID: 28617687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.